Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Institut Gustave Roussy, Villejuif, France

​​​​​​​

Benjamin Besse is Professor of Medical Oncology at Paris-Sud University, Orsay, France and a full-time Cancer Specialist at Gustave Roussy Cancer Campus, Villejuif, France. He gained his Medical Oncology degree in 2005 from Paris-Sud University and holds a PhD in Translational Research.

Currently, Dr Besse is Head of the Thoracic Oncology Unit at Gustave Roussy Cancer Campus. His main research interests are the application of molecular abnormalities to personalise treatment, circulating biomarkers, early drug development in thoracic tumours and thymic malignancies.

Dr Besse is involved in academic research through his position as member of the French Intergroupe Francophone de Cancérologie Thoracique (IFCT) Steering Committee and was elected Chair of the EORTC Lung Group in 2014. He coordinates the French network for thymic malignancies. He is Associate Editor of European Respiratory Journal.

Dr Besse was Chair of the systemic treatment part of the European Society for Medical Oncology Consensus Conference on Lung Cancer published in Annals of Oncology in 2014. He has authored/co-authored more than 100 peer-reviewed papers.